
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 11.270 | 11.270 | 0.000 |
Shares | 90.480 | 90.480 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.681 | 25.481 |
Price to Book | 3.244 | 2.925 |
Price to Sales | 4.331 | 3.863 |
Price to Cash Flow | 21.451 | 17.381 |
Dividend Yield | 3.123 | 1.895 |
5 Years Earnings Growth | 4.090 | 5.647 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 87.420 | 95.707 |
Consumer Cyclical | 6.880 | 0.990 |
Technology | 4.600 | 0.705 |
Industrials | 1.100 | 0.498 |
Number of long holdings: 35
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
WuXi AppTec | CNE1000031K4 | 5.97 | 111.58 | +8.02% | |
Jiangzhong Pharm | CNE000000M80 | 5.91 | 21.93 | +0.32% | |
Yunnan Baiyao A | CNE0000008X7 | 5.85 | 59.29 | +2.97% | |
Dong-E E-Jiao A | CNE0000006Y9 | 5.78 | 51.83 | -0.10% | |
Cr Sanjiu A | CNE0000011K8 | 5.29 | 30.15 | -0.92% | |
Qingdao NovelBeam Technology Co | CNE100005410 | 4.90 | 44.07 | +1.05% | |
HOB Biotech Group | CNE100004C37 | 4.76 | 124.58 | +0.73% | |
Chengdu Olymvax Biopharmaceuticals | CNE1000051H8 | 4.60 | 29.97 | +0.64% | |
Doctorglasses Chain | CNE100002PH4 | 4.45 | 35.79 | -0.69% | |
Mingyue Optical Lens | CNE1000054R1 | 4.42 | 48.17 | -1.15% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Huafu Growth Trend Stock Fund | 602.1M | 14.18 | -5.09 | 5.09 | ||
Huafu Value Growth Dynamic Asset Al | 298.2M | 11.41 | -5.73 | 9.88 | ||
Competit Selected Mixed OpenEnded | 231.83M | 18.91 | -4.29 | 3.57 | ||
Huafu China Securities 100 Index Fu | 229.37M | 5.12 | -0.39 | 6.03 | ||
Huafu YiXin Alloc C | 107.64M | 1.65 | 0.91 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review